Steven Sherman - Dec 4, 2022 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role: Executive Chair, Director
Signature: /s/ Jerome Wong, as Attorney-in-Fact
Stock symbol: EKSO
Transactions as of: Dec 4, 2022
Transactions value $: -$13,492
Form type: 4
Date filed: 12/7/2022, 08:09 PM
Previous filing: Nov 23, 2022
Next filing: May 26, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EKSO	Common Stock	Options Exercise	$0	+31.2K	+4.41%	$0.00	739K	Dec 4, 2022	Direct
transaction	EKSO	Common Stock	Sale	-$13.5K	-10.6K	-1.43%	$1.28^*	729K	Dec 4, 2022	Direct	F1, F2
transaction	EKSO	Common Stock	Award	$0	+243K	+33.3%	$0.00	971K	Dec 4, 2022	Direct	F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EKSO	Restricted Stock Units	Options Exercise	$0	-31.2K	-100%	$0.00^*	0	Dec 4, 2022	Common Stock	31.2K		Direct	F5, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares sold by the Reporting Person on December 7, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the remaining securities under a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022.
F2	The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $1.2700 to $1.3310, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.
F3	The grant of restricted stock units ("RSUs") was approved by the Issuer's Board of Directors on December 4, 2022 in accordance with the terms of the Issuer's Amended and Restated 2014 Equity Incentive Plan. Each RSU represents the economic equivalent of one share of the Issuer's common stock and shall be settled in shares of the Issuer's common stock upon vesting. The RSUs shall fully vest on January 31, 2023.
F4	Includes 242,579 unvested RSUs.
F5	The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date").
F6	On December 4, 2022, the Issuer's Board of Directors approved an amendment to the vesting schedule of the RSUs such that the RSUs fully vested and were delivered to the Reporting Person upon settlement.